New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News For ASNA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
February 11, 2016
10:01 EDTASNAOn The Fly: Analyst Upgrade Summary
Today's noteworthy upgrades include: Artisan Partners (APAM) upgraded to Neutral from Sell at Citi... Ascena Retail (ASNA) upgraded to Neutral from Sell at Goldman... Becton Dickinson (BDX) upgraded to Buy from Hold at Deutsche BankvCisco (CSCO) upgraded to Buy from Hold at Jefferies... C.H. Robinson (CHRW) upgraded at Buckingham... Crown Castle (CCI) upgraded to Conviction Buy from Buy at Goldman... Euronet (EEFT) upgraded to Outperform from Market Perform at Avondale... FibroGen (FGEN) upgraded to Outperform from Neutral at Credit Suisse... First Data (FDC) has hit 'rock bottom,' shares upgraded to Outperform at Credit Suisse... Horace Mann (HMN) upgraded to Buy from Neutral at Janney Capital... Hortonworks (HDP) upgraded to Neutral at Susquehanna... Level 3 (LVLT) upgraded to Overweight on valuation at Morgan Stanley... NCI, Inc. (NCIT) upgraded to Buy from Neutral at SunTrust... Omega Healthcare (OHI) upgraded on results, valuation at JMP Securities... Sun Life Financial (SLF) upgraded to Outperformer from Sector Performer at CIBC... Tanger Factory (SKT) upgraded to Buy from Neutral at Hilliard Lyons... Team (TISI) upgraded to Overweight from Sector Weight at KeyBanc... Tenneco (TEN) upgraded to Overweight from Equal Weight at Barclays... Time Warner (TWX) upgraded to Conviction Buy at Goldman... Ulta Beauty (ULTA) upgraded to Strong Buy from Outperform at Raymond James... Voya Financial (VOYA) upgraded to Neutral from Underweight at JPMorgan... Western Alliance (WAL) upgraded to Buy from Neutral at DA Davidson.
February 10, 2016
16:35 EDTASNAAscena Retail upgraded to Neutral from Sell at Goldman
Goldman analyst Taposh Bari upgraded Ascena Retail to Neutral from Sell, saying shares are more fairly valued after the stock's roughly 50% decline since October. The firm's estimates and $7 price target are unchanged.

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use